RenalytixAI Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease; Solutions to Improve Detection, Management and Treatment of Kidney Disease, Which Impacts More Than 850 Million Globally

  • Barbara Murphy

Press/Media

Period15 Nov 2018

Media coverage

1

Media coverage

  • TitleRenalytixAI Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease; Solutions to Improve Detection, Management and Treatment of Kidney Disease, Which Impacts More Than 850 Million Globally
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date15/11/18
    PersonsBarbara Murphy
View all 1
View less